Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Patient characteristics at baseline

From: General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

Variable

Total

Control

Intervention

p value

 

N = 356

n = 175

(49.2%)

n = 181

(50.8%)

Stratum

   

0.752a

 1 [n (%)]

229 (64.3)

114 (65.1)

115 (63.5)

 

 2 [n (%)]

127 (35.7)

61 (34.9)

66 (36.5)

 

Age: [mean years ± SD]

67.9 ± 13.1

67.5 ± 12.6

68.5 ± 13.5

0.275b

 Median [IQR]

70 [60.0–78.0]

69 [60.0–77.0]

71 [61.0–78.5]

 

 18–65 years [n (%)]

126 (35.4)

63 (36.0)

63 (34.8)

 

 > 65 years [n (%)]

230 (64.6)

112 (64.0)

118 (65.2)

 

 Range

25–96

26–94

25–96

 

Sex

   

0.442a

 Female [n (%)]

192 (53.9)

98 (56.0)

94 (51.9)

 

 Male [n (%)]

164 (46.1)

77 (44.0)

87 (48.1)

 

Number of active medical problems: [mean ± SD]

7.6 ± 3.4

7.9 ± 3.6

7.3 ± 3.3

0.043b

Median [IQR]

7 [5–10]

8 [5–10]

6 [5–9]

 

Number of repeat medicines: [mean ± SD]

10.3 ± 3.6

10.3 ± 3.5

10.3 ± 3.7

0.787b

Median [IQR]

10 [8–12]

10 [8–12]

10 [8–12]

  1. SD standard deviation, IQR interquartile range
  2. aChi-square test
  3. bMann–Whitney U test